Register to learn about warm PDX benefits and onsite expertise
Patient-derived xenograft (PDX) models are a valuable tool in oncology research, helping researchers evaluate therapeutic efficacy in preclinical settings using models that retain key characteristics of human tumours. In this webinar, Crown Bioscience will highlight the capabilities of its PDX model portfolio, with a particular focus on the benefits of warm PDX models and their role in accelerating translational research.
Attendees will learn how warm PDX models can support more efficient study initiation and experimental planning, helping researchers generate meaningful preclinical data to inform drug development decisions. The session will explore the potential advantages of leveraging available models, including opportunities to streamline timelines and support the evaluation of novel oncology therapeutics.
The webinar will also provide a behind-the-scenes overview of how PDX studies are conducted onsite at Crown Bioscience. From model selection and tumour implantation to tumour growth monitoring, treatment administration, and efficacy assessment, speakers will walk through key stages of the PDX workflow and highlight the expertise and operational capabilities that support study execution.
A Q&A with the speakers follows the presentation.